Please Wait
Applying Filters...
menu
    • menu
    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-20

    Virtual Booth

    Contact Supplier

    Menu

    Dacomitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amber Specialty Added to Pfizer’s Limited Distribution Network
    Amber Specialty Added to Pfizer’s Limited Distribution Network

    03 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220803005649/en

    BUSINESSWIRE
    03 Aug 2022
    Share Share
    Daiichi Sankyo Announces Late-Breaking Phase 1 Dose Expansion Data
    Daiichi Sankyo Announces Late-Breaking Phase 1 Dose Expansion Data

    17 Sep 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/daiichi-sankyo-announces-late-breaking-phase-1-dose-expansion-data-for-patritumab-deruxtecan-in-patients-with-egfr-mutated-nsclc-at-esmo-2020/?s=73

    BIOSPACE
    17 Sep 2020
    Share Share
    Three FDA-approved drugs combat COVID in lung cells: report
    Three FDA-approved drugs combat COVID in lung cells: report

    05 Apr 2020

    // Arlene Weintraub FIERCEBIOTECH

    https://www.fiercebiotech.com/research/pfizer-s-vizimpro-among-three-fda-approved-drugs-combat-covid-lung-cells-report

    Arlene Weintraub FIERCEBIOTECH
    05 Apr 2020
    Share Share
    Pfizer Unveils +Ve Results for VIZIMPRO® as 1st line monotherapy in NSCLC
    Pfizer Unveils +Ve Results for VIZIMPRO® as 1st line monotherapy in NSCLC

    27 Nov 2019

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/34/14965/pfizer-unveils-positive-results-for-vizimpro-as-first-line-monotherapy-in-nsclc-patients.html

    BIOSPECTRUM ASIA
    27 Nov 2019
    Share Share
    NICE shuts down AZ's Tagrisso—and backs Pfizer rival Vizimpro instead
    NICE shuts down AZ's Tagrisso—and backs Pfizer rival Vizimpro instead

    09 Jul 2019

    // Carly Helfand FIERCE PHARMA

    https://www.fiercepharma.com/pharma/nice-shuts-down-az-s-tagrisso-and-backs-pfizer-rival-vizimpro-instead?utm_source=internal&utm_medium=rss

    Carly Helfand FIERCE PHARMA
    09 Jul 2019
    Share Share
    NICE OK for life-extending Vizimpro in lung cancer
    NICE OK for life-extending Vizimpro in lung cancer

    06 Jul 2019

    // Anna Smith PHARMATIMES

    http://www.pharmatimes.com/news/nice_ok_for_life-extending_vizimpro_in_lung_cancer_1293312

    Anna Smith PHARMATIMES
    06 Jul 2019
    Share Share